Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

1. Either male or female of age range 18-65 years <br/ >2. Patients with mild to moderate COVID-19 infection and RT-PCR confirmed diagnosis of COVID-19. <br/ >3. Subjects willing to give written informed consent and come for a regular follow up. <br/ >4. Subjects willing to abide by and comply with the study protocol.

1. Either male or female of age range 18-65 years <br/ >2. Patients with mild to moderate COVID-19 infection and RT-PCR confirmed diagnosis of COVID-19. <br/ >3. Subjects willing to give written informed consent and come for a regular follow up. <br/ >4. Subjects willing to abide by and comply with the study protocol.

Nov. 13, 2021, 5:33 p.m. oms

Jan. 15, 2021, 12:45 a.m. oms

1. Either male or female of age range 18-65 years <br/ >2. Patients with mild to moderate COVID-19 infection and RT-PCR confirmed diagnosis of COVID-19. <br/ >3. Subjects willing to give written informed consent and come for a regular follow up. <br/ >4. Subjects willing to abide by and comply with the study protocol.

1. Either male or female of age range 18-65 years <br/ >2. Patients with mild to moderate COVID-19 infection and RT-PCR confirmed diagnosis of COVID-19. <br/ >3. Subjects willing to give written informed consent and come for a regular follow up. <br/ >4. Subjects willing to abide by and comply with the study protocol.